Objectives: TolC is a major outer membrane channel and it plays an important role in the excretion of a wide range of molecules, including antibiotics. A recent study has shown that Salmonella enterica serovar Typhimurium has nine functional drug efflux pumps; however, the TolC dependency of these efflux pumps remains to be studied in detail. The aim of this study was to investigate the TolC dependency of multidrug efflux pumps in this organism.
Introduction
Multidrug efflux pumps cause serious problems in cancer chemotherapy and in the treatment of bacterial infections. In bacteria, resistance to drugs is often associated with multidrug efflux pumps that decrease cellular drug accumulation. 1 In Gram-negative bacteria, pumps belonging to the resistancenodulation -division (RND) family are especially effective in generating resistance, since they form a tripartite complex with the periplasmic proteins of the membrane fusion protein family and the outer membrane channels, ensuring that drugs are pumped out directly to the external medium. The RND pumps often have a wide substrate specificity. 1 Salmonella enterica is a pathogen that causes a variety of diseases in humans, ranging from gastroenteritis to bacteraemia and typhoid fever. In the 1990s, the prevalence of multidrug-resistant S. enterica increased dramatically. Emerging resistance to antibiotics in Salmonella has been found in both humans and animals, and is thus a potentially serious public health problem. High-level fluoroquinolone resistance in S. enterica serovar Typhimurium phage type DT204 has previously been shown to be primarily due to multiple target gene mutations and active efflux by the AcrAB-TolC efflux system belonging to the RND family. 2 The determination of bacterial genome sequences enables us to trace putative drug resistance genes in S. enterica serovar Typhimurium. A recent study has shown that S. enterica serovar Typhimurium has nine functional drug efflux pumps (AcrAB, AcrD, AcrEF, MdtABC, MdsAB, EmrAB, MdfA, MdtK and MacAB) (see Figure 1) . 3 These efflux pumps in S. enterica are classified into four families on the basis of sequence similarity: the major facilitator (MF) family (EmrAB and MdfA); the RND family (AcrAB, AcrD, AcrEF, MdtABC and MdsAB); the multidrug and toxic compound extrusion (MATE) family (MdtK); and the ATP-binding cassette (ABC) family (MacAB). 3 TolC is a major outer membrane channel. In Escherichia coli, it plays an important role in the excretion of a wide range of molecules, including antibiotics, bile salts, organic solvents, Role of TolC in Salmonella drug resistance 1373 JAC enterobactin, several antibacterial peptides, such as colicin V and microcin J25, and also a large protein toxin, a-haemolysin. 4 Although TolC functions as a unique outer membrane channel in these cases, a variety of inner membrane transporters and accessory proteins interact with TolC and enable E. coli to expel structurally diverse molecules. It has been reported that several drug efflux systems in E. coli need TolC to function. 5, 6 TolC is also present in S. enterica, and its deletion increases the susceptibility of S. enterica to many antimicrobial agents and chemical compounds. 2, 3 However, the TolC dependency of the nine drug efflux systems in S. enterica is not fully understood. In this study, we investigated whether multidrug efflux systems in S. enterica require TolC to function.
Materials and methods

Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study are listed in Table S1 [available as Supplementary data at JAC Online (http://jac.oxfordjournals. org/)]. The S. enterica serovar Typhimurium strains were derived from the wild-type strain ATCC 14028s. 7 Bacterial strains were grown at 378C in Luria-Bertani (LB) (1% tryptone/0.5% yeast extract/0.5% NaCl) broth.
Construction of gene deletion mutants
To construct the DacrB and DtolC mutants, gene disruption was performed as described by Datsenko and Wanner. 8 The following oligonucleotide primers were used for the construction of the mutants: acrB-P1 (GCTCA GCCCAGGTCTTAACTTAAACAG GAGCCGTTAAGACGTGTAGGCTGGAGCTGCTTC); acrB-P2 (TAAGCTGTGCTATATCATGTCTTTTGGGTGAGTATTCGTCCATATGAATATC CTCCTTAG); tolC-P1 (TACAAATTGATCAGCGCTAAATACTGCTTCACAACAAGGAG TGTAGGCTGGAGCTGCTTC); and tolC-P2 (TTTTGCGAAATGATGCGTGATGGA TGGATTTTGTCCGTTTCATATGAATATCCTCCTTAG). The chloramphenicol resistance cat gene or the kanamycin resistance aph gene, flanked by Flp recognition sites, was amplified by PCR with the primers listed above. The resulting PCR products were used to transform the recipient ATCC 14028s strain harbouring plasmid pKD46, which expresses Red recombinase. The chromosomal structure of the mutated loci was verified by PCR, as described previously. 8 The cat gene was eliminated by using plasmid pCP20, as described previously. 8 
Plasmid construction
The acrAB, acrD, acrEF, mdtABC, mdsABC, emrAB, mdfA, mdtK and macAB genes were amplified from strain ATCC 14028s genomic DNA by PCR with primers that introduced restriction enzyme sites at both ends of the amplified fragments. The PCR fragments were cloned between the BamHI and SphI sites (SmaI and XbaI sites for mdtABC) of vector pUC118, which resulted in these genes being present in the same orientation and downstream of the lac promoter in the pUC118 vector (Takara Bio Inc., Otsu, Japan). The nucleotide sequences of the recombinant plasmids were determined with an ABI PRISM 3100-Avant Genetic Analyzer.
Determination of MICs of toxic compounds
The MICs of various agents were determined on LB agar plates containing erythromycin, novobiocin, tetracycline, chloramphenicol, nalidixic acid, norfloxacin, doxorubicin, acriflavine, Crystal Violet, ethidium bromide, Methylene Blue, rhodamine 6G, tetraphenylphosphonium bromide, benzalkonium chloride, SDS or sodium deoxycholate (Sigma, St Louis, MO, USA) at various concentrations. Agar plates were made by the 2-fold agar dilution technique, as described previously. 5 To determine MICs, bacteria were grown in LB broth at 378C overnight, diluted into the same medium and then tested at a final inoculum size of 10 5 cfu/mL using a multipoint inoculator (Sakuma Seisakusyo, Tokyo, Japan) after incubation at 378C for 20 h. The MIC was the lowest concentration of compound that inhibited cell growth.
Results and discussion
To investigate whether multidrug efflux systems in S. enterica require TolC to function, all genes encoding the drug efflux systems were cloned into the pUC118 vector. Since the drug efflux system mdsABC operon codes for an outer membrane protein, MdsC, we constructed two different plasmids, pmdsABC and pmdsAB (Table S1 ). These were then transformed into the DacrB and DtolC mutants of S. enterica serovar Typhimurium ATCC 14028s 7 (Table S1 ). We then determined the MICs of 16 toxic compounds for the DacrB and DtolC mutants carrying the plasmids cloned with the nine drug efflux systems ( Table 1) .
Overexpression of all nine drug efflux systems conferred drug resistance to the acrB mutant ( Table 1 ). The plasmids carrying the acrAB or acrEF genes conferred multidrug resistance to all of the tested compounds. The plasmids carrying the acrD or mdtABC genes conferred resistance to novobiocin, SDS and sodium deoxycholate. We also tested the effect of acrD overexpression on the MIC of kanamycin, because aminoglycosides are substrates for AcrD. The kanamycin resistance marker of the acrB mutant (NKS148) was eliminated by using plasmid pCP20 and then pacrD was transformed into the resulting strain. Overproduction of AcrD also conferred resistance to kanamycin (data not shown). Overproduction of MdsABC or MdsAB conferred resistance to novobiocin, acriflavine, Crystal Violet, Methylene Blue, rhodamine 6G, benzalkonium chloride and SDS. Overexpression of the emrAB genes conferred resistance to novobiocin, nalidixic acid, SDS and sodium deoxycholate. The mdfA gene conferred resistance to tetracycline, chloramphenicol, norfloxacin and doxorubicin, the mdtK gene conferred resistance to norfloxacin, doxorubicin and acriflavine, and the macAB gene conferred resistance to erythromycin. These results indicate that all cloned drug efflux genes are functional. This is in agreement with the results of a previous study. 3 In contrast to the results mentioned above, pacrAB, pacrD, pacrEF, pmdsAB, pmdtABC, pemrAB and pmacAB did not confer resistance to the tolC mutant, whereas they conferred drug resistance to the acrB mutant (Table 1) . Only three plasmids (pmdsABC, pmdfA and pmdtK) conferred resistance to the tolC mutant. Overproduction of MdsABC conferred resistance to novobiocin, acriflavine, Crystal Violet, Methylene Blue, rhodamine 6G, benzalkonium chloride and SDS, whereas MdsAB did not confer resistance to the tolC mutant. These data indicate that the drug resistance conferred by the MdsAB system is dependent on the presence of either TolC or MdsC proteins.
We previously reported that overexpression of the nine drug efflux systems confers drug resistance to the acrB mutant; 3 however, it is not fully understood whether these efflux systems require TolC to function. In this study, we identified seven drug efflux systems (AcrAB, AcrD, AcrEF, MdsAB, MdtABC, EmrAB and MacAB) in S. enterica that require TolC to function (Figure 1 ). Not only RND-type efflux pumps, but also MF-type (EmrAB) and ABC-type (MacAB) efflux pumps were TolC dependent. MdsAB was TolC dependent; however, MdsABC did not require TolC, probably because the MdsAB system can function with both TolC and MdsC as an outer membrane component. Overproduction of MdfA or MdtK conferred resistance without TolC, indicating that these are single component efflux systems in the plasma membrane (Figure 1) . Recently, Tal and Schuldiner 9 proposed that single component efflux systems in the plasma membrane transport toxic compounds from the cytoplasm away from their targets, and AcrAB-TolC removes these compounds from the periplasmic space out of the cell. It has also been suggested that the AcrAB-TolC multidrug efflux system is capable of capturing substrates in the periplasmic space rather than in the membrane or from the cytoplasm. 1 This claim is supported by the high-resolution structures of AcrB in which access pathways from the periplasm, but not from the cytoplasm, have been identified. 10 In addition to AcrAB, we found that several drug efflux systems in S. enterica require TolC. These results suggest that multiple TolC-dependent-type drug efflux systems cooperate to export toxic compounds from the periplasmic space out of the cell (Figure 1) . Indeed, when compared with the DacrB mutant, the DtolC mutant was more susceptible to several drugs, especially novobiocin, SDS and sodium deoxycholate. Multiple drug efflux systems may ensure the robustness of Salmonella survival in various natural environments. Further investigation of the cooperation of multidrug efflux systems is required to elucidate the biological significance of multidrug efflux systems in natural environments. Such investigation may provide further insights into the role of multidrug efflux systems in the physiology of the cell.
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